Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Horizon Pharma PLC (NASDAQ:HZNP)

10.20
Delayed Data
As of May 26
 +0.23 / +2.31%
Today’s Change
9.45
Today|||52-Week Range
23.44
-36.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues257.4M273.7M310.3M220.9M
 
 
 
 
 
Cost of Goods Sold28.9M26.3M82.4M67.6M
 
 
 
 
 
Depreciation And Amortization51.9M51.9M67.4M71.5M
 
 
 
 
 
 
Operating ExpensesGross Income176.6M195.4M160.6M81.7M
 
 
 
 
 
General Expenses144.5M144.7M224.7M177.5M
 
 
 
 
 
Research And Development10.7M12.9M24.0M13.1M
 
 
 
 
 
Total Operating Expenses225.3M222.9M374.5M316.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income32.1M50.8M-64.1M-95.8M
 
 
 
 
 
Extraordinary Charge-600.0K-72.1M-66.0M-10.1M
 
 
 
 
 
Interest Expense On Debt19.2M19.1M28.9M32.0M
 
 
 
 
 
Other Expenses-11.0K6.8M-881.0K-224.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income12.2M-33.6M-159.8M-138.1M
 
 
 
 
 
Income Taxes-2.8M-27.7M-29.3M-47.6M
 
 
 
 
 
Net Income15.0M-5.9M-130.5M-90.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS160.5M161.0M161.4M162.0M
 
 
 
 
 
Shares To Calculate EPS Diluted163.9M161.0M161.4M162.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.09-$0.04-$0.81-$0.56
 
 
 
 
 
EPS Diluted$0.09-$0.04-$0.81-$0.56